Virulence Factors in pathogens :mechanisms of infection & disease progression

Year : 2025 | Volume : 02 | Issue : 01 | Page : 6-11
    By

    Alisha Arzoo,

  1. Researcher, Centre for Virology, Jamia Hamdard, Hamdard Nagar, New Delhi, India

Abstract

Pathogens, like bacteria, viruses, fungi, and parasites, have evolved specialized tools – known as virulence factors – that help them infect hosts, escape the immune system, and cause disease. These factors play a key role in determining how severe an infection becomes, how quickly it spreads, and how the body responds. Some pathogens use adhesins to stick to host cells, while others produce toxins that damage tissues or disrupt normal immune functions. Additionally, strategies, like capsule formation and antigenic variation, help microbes stay hidden from the immune system, allowing them to persist and multiply. Understanding how virulence factors work is essential for developing better ways to fight infections. Vaccines can be designed to target specific virulence mechanisms, while new antimicrobial drugs aim to block these harmful processes without harming beneficial microbes. Cutting-edge genetic engineering tools, like CRISPR, are also showing promise in disabling virulence-related genes, offering new hope in the fight against infectious diseases. With antibiotic resistance on the rise, shifting our focus from simply killing pathogens to neutralizing their harmful tactics could lead to more effective and sustainable treatments. By continuing to explore these mechanisms, scientists can develop smarter ways to prevent and treat infections, ultimately protecting public health on a global scale.

Keywords: Virulence factors, pathogenesis, immune evasion, infectious diseases, antimicrobial resistance

[This article belongs to International Journal of Pathogens ]

How to cite this article:
Alisha Arzoo. Virulence Factors in pathogens :mechanisms of infection & disease progression. International Journal of Pathogens. 2025; 02(01):6-11.
How to cite this URL:
Alisha Arzoo. Virulence Factors in pathogens :mechanisms of infection & disease progression. International Journal of Pathogens. 2025; 02(01):6-11. Available from: https://journals.stmjournals.com/ijpg/article=2025/view=206689


References

  1. Finlay BB, Falkow S. Common themes in microbial pathogenicity. Microbiol Rev. 1989;53(2):210–30.
  2. Kline KA, Fälker S, Dahlberg S, Normark S, Henriques-Normark B. Bacterial adhesins in host-microbe interactions. Cell Host Microbe. 2009;5(6):580–92.
  3. Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov. 2010;9(2):117–28.
  4. Bhavsar AP, Guttman JA, Finlay BB. Manipulation of host-cell pathways by bacterial pathogens. Nature. 2007;449(7164):827–34.
  5. Vance RE, Isberg RR, Portnoy DA. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe. 2009;6(1):10–21.
  6. Gonzalez MR, Bischofberger M, Pernot L, van der Goot FG, Frêche B. Bacterial pore-forming toxins: the (w)hole story? Cell Mol Life Sci. 2008;65(3):493–507.
  7. Beveridge TJ. Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol. 1999;181(16):4725–33.
  8. Oliveira PH, Touchon M, Rocha EP. The interplay of restriction-modification systems with mobile genetic elements and their prokaryotic hosts. Nucleic Acids Res. 2014;42(16):10618–31.
  9. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 2007;3(9):541–8.
  10. Allen RC, Popat R, Diggle SP, Brown SP. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol. 2014;12(4):300–8.
  11. Chatterjee S, Haldar S. Antibacterial resistance and alternative strategies to combat bacteria: What do we need to know? Front Pharmacol. 2018;9:555.
  12. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol. 2008;6(1):17–27.
  13. Köhler T, Perron GG, Buckling A, van Delden C. Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog. 2010;6(5):e1000883.
  14. Casadevall A, Pirofski LA. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol. 2003;1(1):17–24.
  15. Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, Balestrino D, et al. The Listeria transcriptional landscape from saprophytism to virulence. Nature. 2009;459(7249):950–6.
Regular Issue Subscription Review Article
Volume 02
Issue 01
Received 28/02/2025
Accepted 06/03/2025
Published 10/03/2025
Publication Time 10 Days
Total Visits: 72


My IP

PlumX Metrics